Indication

Gastric cancer

Gastric cancer is a malignant neoplastic disease that originates in the mucosal lining of the stomach, most commonly manifesting as adenocarcinoma. Read more about Gastric cancer

75 drugs 61 manufacturers

Advertisement

Drugs that treat it

Common Gastric cancer therapies.

Showing 10–18 of 75 drugs

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
TEVA USA

CYRAMZA (ramucirumab)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY·METASTATIC COLORECTAL CANCER·+5
Eli Lilly and Company

FLUOROURACIL

5 FLUOROPYRIMIDINES·METASTATIC COLORECTAL CANCER·+4
APP/NOVAPLUS

CAPECITABINE

MALIGNANT ESOPHAGEAL NEOPLASM·+7
Mylan Pharmaceuticals

FLUOROURACIL

5 FLUOROPYRIMIDINES·METASTATIC COLORECTAL CANCER·+4
APP/PREMIERPRO

FLUOROURACIL

5 FLUOROPYRIMIDINES·METASTATIC COLORECTAL CANCER·+4
BLUEPOINT LABOR

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
ACCORD HEALTHCA

DOCETAXEL

ANTINEOPLASTIC - TAXANES·METASTATIC BREAST CARCINOMA·+5
ACCORD HEALTHCA

DOCETAXEL

ANTINEOPLASTIC - TAXANES·METASTATIC BREAST CARCINOMA·+5
SAGENT PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Gastric cancer preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Gastric cancer.

Gastric cancer is a malignant neoplastic disease that originates in the mucosal lining of the stomach, most commonly manifesting as adenocarcinoma.

It affects the upper gastrointestinal system and predominantly occurs in older adults, frequently developing through a prolonged inflammatory cascade associated with *Helicobacter pylori* infection, dietary exposures, or inherited genetic predispositions.

Pathophysiologically, it is broadly classified into intestinal and diffuse histological subtypes, characterized by glandular formation or diffuse, infiltrative signet-ring cells, respectively.

While early stages are typically asymptomatic or non-specific, disease progression is clinically characterized by persistent epigastric pain, early satiety, progressive dysphagia, hematemesis, melena, and profound involuntary weight loss.

Personalize your experience

Follow Gastric cancer and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it